Sanofi (SNY) Finished Goods (2015 - 2018)

Sanofi (SNY) posted Finished Goods of $2.7 billion for Q4 2018, up 6.3% sequentially from $2.5 billion in Q4 2017, and up 6.3% YoY from $2.5 billion in Q4 2017.

Sanofi (SNY) Finished Goods (2015 - 2018) Analysis & Trends

Sanofi (SNY) has 4 years of Finished Goods data on file, last reported at $2.7 billion in Q4 2018.

  • Quarterly Finished Goods rose 6.3% year-over-year to $2.7 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $2.7 billion (up 6.3% YoY) and the FY2018 annual result came in at $2.7 billion, up 10.83% from the prior year.
  • Finished Goods grew to $2.7 billion in Q4 2018 per SNY's latest filing, from $2.5 billion in the prior quarter.
  • The five-year high for Finished Goods was $2.7 billion in Q4 2018, with the low at $2.3 billion in Q4 2015.
  • Average Finished Goods over 4 years is $2.5 billion, with a median of $2.4 billion recorded in 2017.
  • Year-over-year, Finished Goods grew 1.88% in 2016 and rose 10.02% in 2017.
  • Sanofi's Finished Goods stood at $2.3 billion in 2015, then grew by 1.88% to $2.3 billion in 2016, then increased by 10.02% to $2.5 billion in 2017, then rose by 6.3% to $2.7 billion in 2018.
  • Business Quant data shows SNY's Finished Goods at $2.7 billion in Q4 2018, $2.5 billion in Q4 2017, and $2.3 billion in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Dec 31, 2018 2.71 Bn
Dec 31, 2017 2.55 Bn
Dec 31, 2016 2.32 Bn
Dec 31, 2015 2.27 Bn